Your browser doesn't support javascript.
loading
A randomized, open-label study of a nucleoside analogue reverse transcriptase inhibitor-sparing regimen in antiretroviral-naive HIV-infected patients.
Harris, Marianne; Côté, Hélène; Ochoa, Claudia; Allavena, Clotilde; Negredo, Eugenia; Thorne, Anona; Cahn, Pedro; Zala, Carlos; Raffi, Francois; Clotet, Bonaventura; Singer, Joel; Montaner, Julio.
J Acquir Immune Defic Syndr ; 50(3): 335-7, 2009 Mar 01.
Article in En | MEDLINE | ID: mdl-19242263
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV Protease Inhibitors / Reverse Transcriptase Inhibitors Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2009 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV Protease Inhibitors / Reverse Transcriptase Inhibitors Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2009 Document type: Article Country of publication: